Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N J Hart

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Immunoselection of functional CMRF-56+ blood dendritic cells from multiple myeloma patients for immunotherapyKristen J Radford, Cameron J Turtle, Andrew J Kassianos, et al.
Cancer Immunology, Immunotherapy : CII|August 30, 2011
Human kallikrein 4 signal peptide induces cytotoxic T cell responses in healthy donors and prostate cancer patientsRay Wilkinson, Katherine Woods, Rachael D'Rozario, et al.
The Journal of Experimental Medicine|January 28, 2009
Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host diseaseJohn Wilson, Hannah Cullup, Rohan Lourie, et al.
Transplantation|October 15, 2008
Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host diseaseBrie E Turner, Melinda E Kambouris, Laura Sinfield, et al.
Blood|October 24, 2002
Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantationKelli P A MacDonald, Vanessa Rowe, Cheryl Filippich, et al.
Journal of Immunological Methods|August 8, 2002
Monitoring and isolation of blood dendritic cells from apheresis products in healthy individuals: a platform for cancer immunotherapyJ Alejandro López, Georgina Crosbie, Cathryn Kelly, et al.
British Journal of Haematology|August 30, 2008
Practical blood dendritic cell vaccination for immunotherapy of multiple myelomaF Vari, D J Munster, J L Hsu, et al.
Journal of Immunological Methods|March 1, 2003
Single step enrichment of blood dendritic cells by positive immunoselectionJ Alejandro López, Gilles Bioley, Cameron J Turtle, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2016
Characterization of the Expression and Function of the C-Type Lectin Receptor CD302 in Mice and Humans Reveals a Role in Dendritic Cell MigrationTsun-Ho Lo, Pablo A Silveira, Phillip D Fromm, et al.
Plos One|May 11, 2019
Examination of CD302 as a potential therapeutic target for acute myeloid leukemiaTsun-Ho Lo, Edward Abadir, Robin E Gasiorowski, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Immunoselection of functional CMRF-56+ blood dendritic cells from multiple myeloma patients for immunotherapyKristen J Radford, Cameron J Turtle, Andrew J Kassianos, et al.
Cancer Immunology, Immunotherapy : CII|August 30, 2011
Human kallikrein 4 signal peptide induces cytotoxic T cell responses in healthy donors and prostate cancer patientsRay Wilkinson, Katherine Woods, Rachael D'Rozario, et al.
The Journal of Experimental Medicine|January 28, 2009
Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host diseaseJohn Wilson, Hannah Cullup, Rohan Lourie, et al.
Transplantation|October 15, 2008
Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host diseaseBrie E Turner, Melinda E Kambouris, Laura Sinfield, et al.
Blood|October 24, 2002
Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantationKelli P A MacDonald, Vanessa Rowe, Cheryl Filippich, et al.
Journal of Immunological Methods|August 8, 2002
Monitoring and isolation of blood dendritic cells from apheresis products in healthy individuals: a platform for cancer immunotherapyJ Alejandro López, Georgina Crosbie, Cathryn Kelly, et al.
British Journal of Haematology|August 30, 2008
Practical blood dendritic cell vaccination for immunotherapy of multiple myelomaF Vari, D J Munster, J L Hsu, et al.
Journal of Immunological Methods|March 1, 2003
Single step enrichment of blood dendritic cells by positive immunoselectionJ Alejandro López, Gilles Bioley, Cameron J Turtle, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2016
Characterization of the Expression and Function of the C-Type Lectin Receptor CD302 in Mice and Humans Reveals a Role in Dendritic Cell MigrationTsun-Ho Lo, Pablo A Silveira, Phillip D Fromm, et al.
Plos One|May 11, 2019
Examination of CD302 as a potential therapeutic target for acute myeloid leukemiaTsun-Ho Lo, Edward Abadir, Robin E Gasiorowski, et al.
Pageof 9